ARTHROSAMID

Arthrosamid® is a new, safe and innovative treatment that is designed to relieve and treat pain caused by osteoarthritis. It’s the brand name of a drug that is injected into the knee. It is a single-dose that provides long-acting pain relief without the need for surgery. Patients with knee osteoarthritis experience improved functionality of the knee and a better quality of life as a result of sustained relief of pain and stiffness.

Arthrosamid® is based on hydrogel technology. The non-biodegradable injection is 97.5% water combined with a 2.5% cross-linked polyacrylamide. it works to cushion and lubricate the joint. One Arthrosamid® injection can improve the pain and stiffness of knee osteoarthritis for up to 3 to 5 years. It has been proven to be a safe treatment option that provides long-lasting relief and can improve the overall quality of life. In a significant trial, over 70% of patients reported experiencing these benefits. In clinical trials, the most frequent adverse events observed were mild to moderate injection-related pain or mild swelling during the initial weeks to months following the injection.

Arthrosamid® integrates into the synovium, or lining of the inner joint capsule, creating a cushion-like effect and blocks the inflammation pathways that can cause knee pain. It restores the consistency of the synovial fluid, the lubricating fluid in the knee, improving lubrication and cushioning of the joint.

Contraindications: Treatment with Arthrosamid® may not be safe for patients if there is infection in or around the knee, have haemophilia, take anticoagulant medication, or have had a knee arthroscopy within the past six months. It may be used with caution in patients with poorly controlled diabetes, patients undergoing major dental work, or have been diagnosed with an autoimmune condition.